In conclusion, CXCR2-driven ovarian cancer progression in the peritoneal cavity involves NF-κB mediated CCL20 as a main chemokine network, which would lead to new approaches of ovarian cancer progression and treatment. The gene discussed is CXCR2; the disease is ovarian carcinoma.